Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
09/07/2005 | CN1665926A Human IgM antibody lysing activated lymphocytes under mediation by homologous complement |
09/07/2005 | CN1665925A Factor VII or VIIa polypeptide variants |
09/07/2005 | CN1665922A Medium for culturing autologous human progenitor stem cells and applications thereof |
09/07/2005 | CN1665921A Adenovirus vectors for immunotherapy |
09/07/2005 | CN1665920A Liver engrafting cells, assays, and uses thereof |
09/07/2005 | CN1665918A Culture dish and bioreactor system |
09/07/2005 | CN1665561A Microstructures for delivering a composition cutaneously to skin |
09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
09/07/2005 | CN1665527A Vascularization enhanced graft constructs |
09/07/2005 | CN1665488A Direct cellular energy delivery system |
09/07/2005 | CN1665487A Liposomal vaccine |
09/07/2005 | CN1665458A Injectable chondrocyte implant |
09/07/2005 | CN1665391A Methods of expressing LIM mineralization protein in non-osseous cells |
09/07/2005 | CN1665388A Sterilization, stabilization and preservation of functional biologics |
09/07/2005 | CN1664095A EPSP synthase of variable halomonas high resistance glyphosate and its encoding sequence |
09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
09/07/2005 | CN1663561A Use of rare earth element salt in preparation of insulin beta cell for treating diabetes |
09/07/2005 | CN1663431A Process for preparing wheat seedling powder buckwheat bud |
09/07/2005 | CN1663359A Method for culturing embryoid of woody plant anther |
09/07/2005 | CN1218182C Method for separating cells using immunorosettes |
09/06/2005 | US6940001 Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein |
09/06/2005 | US6939959 Efficient protein expression system |
09/06/2005 | US6939949 Protein for use in diagnosis and treatment of cancer |
09/06/2005 | US6939945 Synthetic peptide for use as tool in human therapeutics and diagnostics |
09/06/2005 | US6939862 Method for transferring nucleic acid into striated muscles |
09/06/2005 | US6939712 for expression inhibition/knockout of collagen, tumor necrosis factor, tat genes/proteins, and immunoglobulins |
09/06/2005 | US6939711 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
09/06/2005 | US6939699 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria |
09/06/2005 | US6939670 Cell-based detection and differentiation of lung cancer |
09/06/2005 | US6939669 Expansion of hematopoietic cells using midkine or pleiotrophin |
09/06/2005 | US6939540 nucleic acid encoding an angiogenic protein is administered to a cell in a region of a bone such that the nucleic acid is expressed to produce the angiogenic protein, whereby bone density or formation is enhanced within the region |
09/06/2005 | US6939378 Microfabricated tissue as a substrate for pigment epithelium transplantation |
09/06/2005 | CA2307832C A method of improved mixing of a varicella-infected cell culture in roller bottles |
09/06/2005 | CA2250693C Compositions and methods for taxol biosynthesis |
09/06/2005 | CA2160034C Gibbon ape leukemia virus-based retroviral vectors |
09/05/2005 | CA2460602A1 Pancreatic multipotent progenitor cells |
09/03/2005 | CA2457303A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
09/01/2005 | WO2005080986A1 Antibodies to phosphorylated tau, methods of making and methods of use |
09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
09/01/2005 | WO2005080555A1 Monoclonal antibody specific to cell surface protein of human embroyonic stem cell |
09/01/2005 | WO2005080554A1 Method of controlling the differentiation of embryonic stem cells |
09/01/2005 | WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement |
09/01/2005 | WO2005080552A1 Methods for genetic diversification in gene conversion active cells |
09/01/2005 | WO2005080551A2 Stem cells |
09/01/2005 | WO2005080547A1 Patterning substrate for cell culture |
09/01/2005 | WO2005080545A2 Method for the production of recombined proteins in eukaryontic host cells |
09/01/2005 | WO2005080544A2 Cell/tissue culturing device, system and method |
09/01/2005 | WO2005080431A2 Monoclonal antibodies that specifically bind to folate receptor alpha |
09/01/2005 | WO2005079994A1 Device and method for separation and recovery |
09/01/2005 | WO2005079881A1 Arthroscopic method for cell implantation in mammals |
09/01/2005 | WO2005079879A1 Collagen gel and process for producing the same |
09/01/2005 | WO2005079820A1 Immunopotentiator |
09/01/2005 | WO2005079728A1 Method of regenerating dentin |
09/01/2005 | WO2005079581A1 Intratumoral delivery of dendritic cells |
09/01/2005 | WO2005079532A2 Methods and compositions for enhancing risc activity in vitro and in vivo |
09/01/2005 | WO2005079271A2 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
09/01/2005 | WO2005079267A2 Methods for protein production |
09/01/2005 | WO2005079250A2 Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom |
09/01/2005 | WO2005079204A2 Artificial synapse chip |
09/01/2005 | WO2005079145A2 Tissue system with undifferentiated stem cells derived from corneal limbus |
09/01/2005 | WO2005059088B1 Cultured cell and method and apparatus for cell culture |
09/01/2005 | WO2005030967A3 Crop plant cystatin proteinase inhibitors and methods of use |
09/01/2005 | WO2005030966A3 Regulation of plant biomass and stress tolerance |
09/01/2005 | WO2004099387A3 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS |
09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
09/01/2005 | WO2004044553A3 Lepidoptera voltage-gated calcium channels |
09/01/2005 | WO2004039939A3 Textiles for use in bioreactors |
09/01/2005 | WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
09/01/2005 | WO2002083873A3 Enzymes |
09/01/2005 | US20050193447 Enhance drought tolerance of plant by transform with vector containing signal transduction polynucleotide sequence to produce a transgenic plant |
09/01/2005 | US20050193443 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments |
09/01/2005 | US20050193442 Soybean cultivar 70826751 |
09/01/2005 | US20050193441 For producing a disease resistant soybean plant |
09/01/2005 | US20050193440 Soybean cultivar 0509246 |
09/01/2005 | US20050193439 Soybean cultivar 0509253 |
09/01/2005 | US20050193438 Plants exhibit male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, decreased phylate content, modified carbohydrate metabolism and resistance to bacterial disease, fungal disease or viral disease |
09/01/2005 | US20050193437 Soybean cultivar 0509252 |
09/01/2005 | US20050193436 herbicide resistant, insect resistant, disease resistant transgenic plants and seeds |
09/01/2005 | US20050193435 Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens) |
09/01/2005 | US20050193432 Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof |
09/01/2005 | US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system |
09/01/2005 | US20050191745 Cultures of GFAP nestin cells that differentiate to neurons |
09/01/2005 | US20050191744 Propagating vascular tissues comprising vascular endothelial growth factor receptor (VEGFR) from embryonic stem cells; regenerative medicine |
09/01/2005 | US20050191743 Using biological scaffold to propagate lymphocytic cells |
09/01/2005 | US20050191742 Trophoblast cell preparations |
09/01/2005 | US20050191739 Polyphenol oxidase genes from banana, lettuce, tobacco and pineapple |
09/01/2005 | US20050191738 Modified reductase and its gene, and use thereof |
09/01/2005 | US20050191735 Oxidoreductase |
09/01/2005 | US20050191727 Modified viral sequences which enhance genic expression in microorganismal host |
09/01/2005 | US20050191723 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
09/01/2005 | US20050191721 Tim-3 (t cell immunoglobulin and mucin domain containing molecule) polypeptide for use in enhancement of immune and transplantaion tolerance |
09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
09/01/2005 | US20050191673 Nucleotide sequences coding tumor marker genes for use as tool in classification, diagnosis and prognosis of cell proliferative disorders |
09/01/2005 | US20050191658 Allelic series of genomic modifications in cells |
09/01/2005 | US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders |
09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
09/01/2005 | US20050191356 Porous and non-porous matrices based on chitosan and hydroxy carboxylic acids |